Article
Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.
Toxicologic pathology - 1 Oct 2017
Wilson Kristin, Faelan Crystal, Patterson-Kane Janet C, Rudmann Daniel G, Moore Steven A, Frank Diane, Charleston Jay, Tinsley Jon, Young G David, Milici Anthony J
Abstract excerpt
Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are neuromuscular disorders that primarily affect boys due to an X-linked mutation in the DMD gene, resulting in reduced to near absence of dystrophin or expression of truncated forms of dystrophin. Some newer therapeutic interventions aim to increase sarcolemmal dystrophin expression, and accurate dystrophin quantification is critical for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
